510(k) K042884
K042884 is an FDA 510(k) premarket notification submitted by Dakocytomation California, Inc. for the device "DAKOCYTOMATION ER/PR PHARMDX KIT". The FDA issued a decision of Substantially Equivalent on Feb 15, 2005. The device falls under product code MXZ (Immunohistochemistry Assay, Antibody, Progesterone Receptor), a Class II device regulated under 21 CFR 864.1860. Dakocytomation California, Inc. has 1 other 510(k) clearance on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 15, 2005
- Date Received
- Oct 19, 2004
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Immunohistochemistry Assay, Antibody, Progesterone Receptor
- Device Class
- Class II
- Regulation Number
- 864.1860
- Review Panel
- PA
- Submission Type
- 510(k)
Need the full FDA record for Dakocytomation California, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.